Assignee
SOLVAY PHARM BV
NL·57 granted patents·23 pending applications·325 citations·filing 2000–2011
Top patents by PatentIndex Score
80 records- 0192US6476060B24,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activitySOLVAY PHARM BV·Filed 2001·Granted Nov 5, 2002·78 cites·24 claims
- 0287US6974810B24,5-Dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activitySOLVAY PHARM BV·Filed 2002·Granted Dec 13, 2005·31 cites·9 claims
- 0386US7728018B2Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-HT6 antagonistsSOLVAY PHARM BV·Filed 2007·Granted Jun 1, 2010·11 cites·11 claims
- 0486US7524867B2Tetrasubstituted imidazole derivatives as cannabinoid CB1 receptor modulators with a high CB1/CB2 receptor subtype selectivitySOLVAY PHARM BV·Filed 2005·Granted Apr 28, 2009·10 cites·11 claims
- 0585US7923026B2Embedded micellar nanoparticlesSOLVAY PHARM BV·Filed 2007·Granted Apr 12, 2011·26 cites·22 claims
- 0684US7964604B2Bifeprunox mesylate maintenance dose compositions and methods for using the sameSOLVAY PHARM BV·Filed 2007·Granted Jun 21, 2011·10 cites·34 claims
- 0782US7528162B24,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activitySOLVAY PHARM BV·Filed 2002·Granted May 5, 2009·20 cites·16 claims
- 0882US7189525B2Human enzymes of the metalloprotease familySOLVAY PHARM BV·Filed 2006·Granted Mar 13, 2007·5 cites·3 claims
- 0981US7109216B21H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1-antagonistic activitySOLVAY PHARM BV·Filed 2004·Granted Sep 19, 2006·14 cites·13 claims
- 1079US7786126B2Combination preparations comprising SLV308 and a dopamine agonistSOLVAY PHARM BV·Filed 2007·Granted Aug 31, 2010·1 cites·19 claims
- 1179US7319110B21H-1,2,4-triazole-3-carboxamide derivatives having cannabinoid-CB1 receptor agonistic, partial agonistic, inverse agonistic or antagonistic activitySOLVAY PHARM BV·Filed 2003·Granted Jan 15, 2008·14 cites·4 claims
- 1278US6828325B2PhenylpiperazinesSOLVAY PHARM BV·Filed 2002·Granted Dec 7, 2004·13 cites·5 claims
- 1376US7786144B2Sulphur containing pyrazole derivatives as selective cannabinoid CB1 receptor antagonistsSOLVAY PHARM BV·Filed 2007·Granted Aug 31, 2010·2 cites·13 claims
- 1476US7608718B24,5-dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activitySOLVAY PHARM BV·Filed 2005·Granted Oct 27, 2009·2 cites·2 claims
- 1576US7371737B22-substituted-6-trifluoromethyl purine derivatives with adenosine-A3 antagonistic activitySOLVAY PHARM BV·Filed 2005·Granted May 13, 2008·4 cites·15 claims
- 1675US7964728B2Azaindole derivatives with a combination of partial nicotinic acetyl-choline receptor agonism and dopamine reuptake inhibitionSOLVAY PHARM BV·Filed 2007·Granted Jun 21, 2011·2 cites·7 claims
- 1773US6958396B28-{4-[3-(5-fluoro-1H-indol-3-YL)-Propyl]-Piperazin-1-YL}-2-methyl-4H-Benzo[1,4]oxazin-3-one mesylate with high affinity for the dopamine D2 receptor and the serotonin reuptake siteSOLVAY PHARM BV·Filed 2002·Granted Oct 25, 2005·7 cites·6 claims
- 1872US7709024B2Sustained-release formulation and uses thereofSOLVAY PHARM BV·Filed 2006·Granted May 4, 2010·1 cites·9 claims
- 1971US7307079B21,3,5-Triazine derivatives as ligands for human adenosine-A3 receptorsSOLVAY PHARM BV·Filed 2003·Granted Dec 11, 2007·9 cites·14 claims
- 2071US6911448B2Piperazine and piperidine compoundsSOLVAY PHARM BV·Filed 2001·Granted Jun 28, 2005·5 cites·10 claims
- 2170US7776860B2Process for the preparation of 3-amino-8-(1-piperazinyl)-2H-1-benzopyran-2-one and salts and solvates thereofSOLVAY PHARM BV·Filed 2005·Granted Aug 17, 2010·1 cites·6 claims
- 2270US7678789B2[1,2,4]-dithiazoli(di)ne derivatives, inducers of gluthathione-S-transferase and NADPH quinone oxido-reductase, for prophylaxis and treatment of adverse conditions associated with cytotoxicity in general and apoptosis in particularSOLVAY PHARM BV·Filed 2006·Granted Mar 16, 2010·1 cites·6 claims
- 2370US7371769B2Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-D2 receptors and serotonin reuptake sitesSOLVAY PHARM BV·Filed 2005·Granted May 13, 2008·1 cites·18 claims
- 2470US7186741B2Neurotensin active 2,3,diaryl-pyrazolidine derivativesSOLVAY PHARM BV·Filed 2003·Granted Mar 6, 2007·6 cites·4 claims
- 2569US7405216B2Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)SOLVAY PHARM BV·Filed 2004·Granted Jul 29, 2008·4 cites·25 claims
- 2669US7244734B2Hexa- and octahydro-pyrido[1,2-a]pyrazine derivatives with NK1 antagonistic activitySOLVAY PHARM BV·Filed 2004·Granted Jul 17, 2007·6 cites·8 claims
- 2769US6855532B2Human enzymes of the metalloprotease familySOLVAY PHARM BV·Filed 2002·Granted Feb 15, 2005·3 cites·22 claims
- 2868US7851630B2Hydronopol substituted benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptorsSOLVAY PHARM BV·Filed 2004·Granted Dec 14, 2010·4 cites·6 claims
- 2967US7067513B1PhenylpiperazinesSOLVAY PHARM BV·Filed 2000·Granted Jun 27, 2006·3 cites·7 claims
- 3065US7750013B2N-oxides as prodrugs of piperazine and piperidine derivativesSOLVAY PHARM BV·Filed 2006·Granted Jul 6, 2010·1 cites·8 claims
- 3163US7202238B2Diazabicyclo alkane derivatives with NK1 antagonistic activitySOLVAY PHARM BV·Filed 2003·Granted Apr 10, 2007·4 cites·6 claims
- 3262US7605162B2PhenylpiperazineSOLVAY PHARM BV·Filed 2008·Granted Oct 20, 2009·0 cites·6 claims
- 3360US7495108B2Imidazoline derivatives having CB1-antagonistic activitySOLVAY PHARM BV·Filed 2007·Granted Feb 24, 2009·0 cites·5 claims
- 3460US7312321B2Antibody to human enzymes of the metalloprotease familySOLVAY PHARM BV·Filed 2007·Granted Dec 25, 2007·0 cites·2 claims
- 3560US6998398B2Solid salts of benzazepine compounds and pharmaceutical compositions containing themSOLVAY PHARM BV·Filed 2004·Granted Feb 14, 2006·3 cites·15 claims
- 3660US2008070259A1Novel Human Enzymes of the Metalloprotease FamilySOLVAY PHARM BV·Filed 2007·Application pending·0 cites
- 3759US7524853B2Compounds and their use in therapySOLVAY PHARM BV·Filed 2004·Granted Apr 28, 2009·1 cites·40 claims
- 3858US7928134B25-aryl-4,5-dihydro-(1H)-pyrazolines as cannabinoid CB1 receptor agonistsSOLVAY PHARM BV·Filed 2008·Granted Apr 19, 2011·0 cites·11 claims
- 3958US2010010062A1Method of treatment using eprosartanSOLVAY PHARM BV·Filed 2009·Application pending·0 cites
- 4057US7083965B2Human enzymes of the metalloprotease familySOLVAY PHARM BV·Filed 2004·Granted Aug 1, 2006·0 cites·6 claims
- 4157US7015333B2Process for preparation of imidazolyl compoundsSOLVAY PHARM BV·Filed 2003·Granted Mar 21, 2006·2 cites·10 claims
- 4256US8034379B2Ion-strength independent sustained release pharmaceutical formulationSOLVAY PHARM BV·Filed 2001·Granted Oct 11, 2011·2 cites·34 claims
- 4356US7915262B2Combination preparations comprising SLV308 and a dopamine agonistSOLVAY PHARM BV·Filed 2010·Granted Mar 29, 2011·0 cites·2 claims
- 4455USD589606SPharmaceutical tabletSOLVAY PHARM BV·Filed 2008·Granted Mar 31, 2009·15 cites·1 claims
- 4555US7498348B21 H-imidazole derivatives as cannabinoid receptor modulatorsSOLVAY PHARM BV·Filed 2007·Granted Mar 3, 2009·0 cites·3 claims
- 4655US7173044B2Imidazoline derivatives having CB1-antagonistic activitySOLVAY PHARM BV·Filed 2005·Granted Feb 6, 2007·0 cites·7 claims
- 4754US7595310B2Glucuronate salt of a piperazine compoundSOLVAY PHARM BV·Filed 2006·Granted Sep 29, 2009·0 cites·25 claims
- 4854US6998255B1Human G-protein coupled receptorSOLVAY PHARM BV·Filed 2000·Granted Feb 14, 2006·2 cites·41 claims
- 4953US7696383B2N-oxides of venlafaxine and o-desmethylvenlafaxine as prodrugsSOLVAY PHARM BV·Filed 2008·Granted Apr 13, 2010·0 cites·11 claims
- 5053US7615551B2Salicylate and gentisate salts of a piperazine compoundSOLVAY PHARM BV·Filed 2006·Granted Nov 10, 2009·0 cites·25 claims
Showing the top 50 of 80 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →